Center-Authored Papers

Filters: Author is Hubbell, F Allan  [Clear All Filters]
Journal Article
Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg C, Wactawski-Wende J, Rohan T, O'Sullivan MJ, Yasmeen S, Hiatt RA et al..  2011.  25-hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women.. Maturitas. 68(1):73-8. Abstract
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O'Sullivan MJ, Yasmeen S et al..  2008.  Calcium plus vitamin D supplementation and the risk of breast cancer.. Journal of the National Cancer Institute. 100(22):1581-91. Abstract
Prentice RL, Pettinger M, Beresford SAA, Wactawski-Wende J, Hubbell AF, Stefanick ML, Chlebowski RT.  2009.  Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(5):1531-7. Abstract
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH et al..  2008.  Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.. American journal of epidemiology. 167(12):1407-15. Abstract
Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell AF, Lane D et al..  2012.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.. The lancet oncology. 13(5):476-486. Abstract
Chlebowski RT, Anderson G, Manson JE, Pettinger M, Yasmeen S, Lane D, Langer RD, Hubbell AF, McTiernan A, Hendrix S et al..  2010.  Estrogen alone in postmenopausal women and breast cancer detection by means of mammography and breast biopsy.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(16):2690-7. Abstract
Lavasani S, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R, Hubbell AF, Mahinbakht A et al..  2015.  Estrogen and colorectal cancer incidence and mortality.. Cancer. Abstract
Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC, Muskovitz A, Kato I, Young A, Hubbell AF, Prentice RL.  2012.  Estrogen plus progestin and colorectal cancer incidence and mortality.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(32):3983-90. Abstract
Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell AF, Kooperberg C, Kuller LH, Lane DS et al..  2008.  Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.. American journal of epidemiology. 167(10):1207-16. Abstract
Banegas MP, Gail MH, Lacroix A, Thompson B, Martinez ME, Wactawski-Wende J, John EM, Hubbell AF, Yasmeen S, Katki HA.  2012.  Evaluating breast cancer risk projections for Hispanic women.. Breast cancer research and treatment. 132(1):347-353. Abstract
Schwartz AG, Ray RM, Cote ML, Abrams J, Sokol RJ, Hendrix SL, Chen C, Chlebowski RT, Hubbell AF, Kooperberg C et al..  2015.  Hormone Use, Reproductive History and Risk of Lung Cancer: The Women's Health Initiative Studies.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. Abstract
Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, Rodabough RJ, Johnson KC, Wactawski-Wende J, Kotchen JM et al..  2010.  Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial.. Journal of the National Cancer Institute. 102(18):1413-21. Abstract
Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough RJ, Chien JW, Wactawski-Wende J, Gass M et al..  2009.  Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial.. Lancet. 374(9697):1243-51. Abstract
Livaudais JC, Lacroix A, Chlebowski RT, Li CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell AF, Coronado GD.  2013.  Racial/Ethnic Differences in Use and Duration of Adjuvant Hormonal Therapy for Breast Cancer in the Women's Health Initiative.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract